Literature DB >> 10328533

Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus.

K Hawrami1, J Breuer.   

Abstract

A TaqMan based polymerase chain reaction (PCR) assay was developed for the detection and quantitation of varicella zoster virus (VZV). This method enables simple, reproducible, sensitive and specific detection and quantification of VZV. The TaqMan assay was able to detect four copies of VZV and did not cross-react with other herpesviruses DNA. The assay has several advantages over conventional PCR. First, in the TaqMan assay there is no need for gel electrophoresis and contact with hazardous chemicals. Second, the method is rapid allowing the analysis of 92 samples within minutes after completion of PCR. Finally, the incorporation of a specific probe into the PCR reaction enhances the sensitivity and specificity of the method compared with conventional PCR. The TaqMan system could, therefore, be a useful tool for the epidemiological and diagnostic investigation of VZV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328533     DOI: 10.1016/s0166-0934(98)00176-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  24 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus.

Authors:  J D Callahan; S J Wu; A Dion-Schultz; B E Mangold; L F Peruski; D M Watts; K R Porter; G R Murphy; W Suharyono; C C King; C G Hayes; J J Temenak
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 3.  Real-time PCR in virology.

Authors:  Ian M Mackay; Katherine E Arden; Andreas Nitsche
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

4.  Two cases of varicella zoster virus keratitis with atypical extensive pseudodendrites.

Authors:  Michiko Kandori; Tomoyuki Inoue; Fumihiko Takamatsu; Yuichi Hori; Naoyuki Maeda; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

5.  Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes.

Authors:  V N Loparev; K McCaustland; B P Holloway; P R Krause; M Takayama; D S Schmid
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence.

Authors:  M D de Jong; J F Weel; T Schuurman; P M Wertheim-van Dillen; R Boom
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

7.  Quantitation of varicella-zoster virus DNA in patients with Ramsay Hunt syndrome and zoster sine herpete.

Authors:  Y Furuta; F Ohtani; H Sawa; S Fukuda; Y Inuyama
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

8.  Diagnosing herpesvirus infections by real-time amplification and rapid culture.

Authors:  G J J van Doornum; J Guldemeester; A D M E Osterhaus; H G M Niesters
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.

Authors:  Chandrav De; Dongmei Liu; Bo Zheng; Uma S Singh; Satish Chavre; Catherine White; Robert D Arnold; Fred K Hagen; Chung K Chu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2014-07-19       Impact factor: 5.970

10.  Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus.

Authors:  Shannon L Taylor; Paul R Kinchington; Andrew Brooks; Jennifer F Moffat
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.